- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Alpha- mannosidosis
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
Velmanase Alpha – July 2025
Velmanase Alpha; Powder for I.V. infusion 10 mg; Lamzede®
Last updated
9 July 2025
